medigraphic.com
ISSN 1405-8871 (Print)

2024, Number 3

<< Back Next >>

Aten Fam 2024; 31 (3)

Prevalence of Neuropathy Associated with Frailty in Geriatric Patients

Morales-Servin AC, Alvarado-Gutiérrez T, Vega-Blancas JL

Language: Spanish
References: 20
Page: 165-169
PDF size: 179.68 Kb.


ABSTRACT

Objective: To analyze the prevalence of neuropathy associated with frailty in geriatric patients attending the Family Medicine Unit (UMF ) No. 31. Methods: An analytical cross-sectional study, a sample of 368 patients was obtained using the finite population formula, then non-probability sampling by quota was performed. Patients over 65 years of age at FMU No. 31 of the Mexican Institute of Social Security were evaluated, and the presence of neuropathic pain and frailty syndrome were analyzed using the DN 4 and Fried questionnaires, respectively; their association was evaluated using inferential statistics. Results: Neuropathy was identified in 69.56% of patients, and frailty in 77.4%. There was a concurrence of the two entities in 64.40%. Conclusion: There is a high prevalence of patients with frailty syndrome and neuropathy. These findings suggest a significant association between neuropathy and frailty in this population, emphasizing the importance of considering both aspects in the care of this age group.


REFERENCES

  1. Instituto Mexicano del Seguro Social. Guía dePráctica Clínica GPC Prevención, Diagnóstico yTratamiento del Síndrome de Fragilidad en el Anciano[Internet]. [Citado 2023 Nov 13]. Disponibleen: https://www.imss.gob.mx/sites/all/statics/guiasclinicas/479GER_0.pdf

  2. Vásquez M. La fragilidad del paciente geriátricocomo un indicador de riesgo para complicaciónpostoperatoria. Revista Mexicana de Anestesiología.2018;41(1):53–57.

  3. Masel MC, Ostir GV, Ottenbacher KJ. Frailty,mortality, and health-related quality of life inolder Mexican Americans. J Am Geriatr Soc.2010;58(11):2149-53.

  4. Tello-Rodríguez T, Varela-Pinedo L. Fragilidaden el adulto mayor: detección, intervención en lacomunidad y toma de decisiones en el manejo deenfermedades crónicas. Rev. Perú. med. exp. saludpública. 2016; 33( 2 ): 328-334.

  5. Hoogendijk EO, Afilalo J, Ensrud, KE, KowalP, Onder G,Fried, LP. Frailty: implications forclinical practice and public health. The Lancet.2019;394(10206):1365–1375.

  6. Velasco M. Dolor neuropático. Revista MédicaClínica las Condes. 2014;25(4):625–631.

  7. Rincón-Carvajal M, Olaya-Osorio A, Martínez-Rojas S, Ibatá-Bernal L. Recomendaciones basadasen evidencia para el manejo del dolor neuropáticoen Atención Primaria en Salud. Rev Soc Esp Dolor.2018;25(6): 349-358.

  8. Blanco E, Galvez R, Zamorano E, López V, PérezM. Prevalencia del dolor neuropático (DN),según DN4, en atención primaria. Semergen.2012;38(4):203–210

  9. Oliveira FMRL, Barbosa KTF, Rodrigues MMP,Fernandes MGM. Frailty syndrome in the elderly:conceptual analysis according to Walker and Avant.Rev Bras Enferm. 2020;73(Suppl 3):e20190601.

  10. Spallone V, Morganti R, D’Amato C, Greco C,Cacciotti L, Marfia GA. Validation of DN4 asa screening tool for neuropathic pain in painfuldiabetic polyneuropathy. Diabet Med.2012;29(5):578-585.

  11. Alcántara MA, Ibor VPJ, Alonso VA, Trillo CE.Actualización en el tratamiento farmacológico deldolor neuropático. Semergen. 2019;45(8):535–545

  12. Guerrero-Rojas G. Síndrome de fragilidad en eladulto mayor: una revisión sistematizada. Rev MexEnferm Cardiol. 2021;29(3):97-111

  13. Perez-Zepeda MU, Rodriguez MA, Wong R. Envejecimientoen México: Fragilidad. [Internet].[Citado 2023 Nov 10]. Disponible en: https://www.mhasweb.org/images/MHASFactSheet_Frailty_SPANISH.pdf

  14. Abizanda-Soler P. Actualización en fragilidad. RevEsp Geriatr Gerontol. 2010;45(2):106–110.

  15. Avila-Funes JA, Helmer C, Amieva H, Barberger-Gateau P, Le Goff M, Ritchie K, Portet F, CarrièreI, et al. Frailty among community-dwelling elderlypeople in France: the three-city study. J GerontolA Biol Sci Med Sci. 2008;63(10):1089-1096.

  16. Navarrete-Reyes AP, Ávila-Funes JA. Diabetesmellitus y el síndrome de fragilidad en el anciano.Medigraphic. 2010;62(4): 327-332.

  17. Nascimento CM, Ingles M, Salvador-Pascual A,Cominetti MR, Gomez-Cabrera MC, Viña J. Sarcopenia,frailty and their prevention by exercise.Free Radic Biol Med. 2018;20(132):42-49.

  18. Abd Ghafar MZA, O’Donovan M, Sezgin D, MoloneyE, Rodríguez-Laso Á, Liew A, O’CaoimhR. Frailty and diabetes in older adults: Overviewof current controversies and challenges inclinical practice. Front Clin Diabetes Healthc.2022;19(3):1-8.

  19. Nuha A, ElSayed, Grazia A, Vanita R, Aroda, RaveendharaR, et al. Standards of Care in Diabetes.American Diabetes Association. 2023;46(1):5–9.

  20. Walston J, Buta B, Xue QL. Frailty Screening andInterventions: Considerations for Clinical Practice.Clin Geriatr Med. 2018;34(1):25-38.




2020     |     www.medigraphic.com